The newly created private-equity firm was formed to serve the rapid expansion of Paragon Biosciences’ portfolio of life science companies CHICAGO, August 20, 2019-- Paragon Biosciences LLC – the Chicago-based life science innovator that invests in, builds, and advises bioscience companies – is announcing the formation of Paragon Health Capital, LLC. Brian Friedman, a financial industry veteran with over 20 years of experience in health care investment banking and venture capital, will serve as CEO of the newly created private-equity firm.